BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 26119306)

  • 21. The resveratrol trimer miyabenol C inhibits β-secretase activity and β-amyloid generation.
    Hu J; Lin T; Gao Y; Xu J; Jiang C; Wang G; Bu G; Xu H; Chen H; Zhang YW
    PLoS One; 2015; 10(1):e0115973. PubMed ID: 25629409
    [TBL] [Abstract][Full Text] [Related]  

  • 22. IL-1R
    Wang H; Peng G; Wang B; Yin H; Fang X; He F; Zhao D; Liu Q; Shi L
    Brain Res Bull; 2020 Apr; 157():10-17. PubMed ID: 32004659
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential regulation of amyloid precursor protein sorting with pathological mutations results in a distinct effect on amyloid-β production.
    Lin YC; Wang JY; Wang KC; Liao JY; Cheng IH
    J Neurochem; 2014 Nov; 131(4):407-12. PubMed ID: 25053581
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Autosomal-dominant Alzheimer's disease mutations at the same codon of amyloid precursor protein differentially alter Aβ production.
    Suárez-Calvet M; Belbin O; Pera M; Badiola N; Magrané J; Guardia-Laguarta C; Muñoz L; Colom-Cadena M; Clarimón J; Lleó A
    J Neurochem; 2014 Jan; 128(2):330-9. PubMed ID: 24117942
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Amino-truncated amyloid beta-peptide (Abeta5-40/42) produced from caspase-cleaved amyloid precursor protein is deposited in Alzheimer's disease brain.
    Takeda K; Araki W; Akiyama H; Tabira T
    FASEB J; 2004 Nov; 18(14):1755-7. PubMed ID: 15364896
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of proteolysis in Alzheimer's disease.
    Hooper NM; Trew AJ; Parkin ET; Turner AJ
    Adv Exp Med Biol; 2000; 477():379-90. PubMed ID: 10849764
    [TBL] [Abstract][Full Text] [Related]  

  • 27. γ-Secretase in microglia - implications for neurodegeneration and neuroinflammation.
    Walter J; Kemmerling N; Wunderlich P; Glebov K
    J Neurochem; 2017 Nov; 143(4):445-454. PubMed ID: 28940294
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Advances in the identification of γ-secretase inhibitors for the treatment of Alzheimer's disease.
    D'Onofrio G; Panza F; Frisardi V; Solfrizzi V; Imbimbo BP; Paroni G; Cascavilla L; Seripa D; Pilotto A
    Expert Opin Drug Discov; 2012 Jan; 7(1):19-37. PubMed ID: 22468891
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cryptotanshinone, a compound from Salvia miltiorrhiza modulates amyloid precursor protein metabolism and attenuates beta-amyloid deposition through upregulating alpha-secretase in vivo and in vitro.
    Mei Z; Zhang F; Tao L; Zheng W; Cao Y; Wang Z; Tang S; Le K; Chen S; Pi R; Liu P
    Neurosci Lett; 2009 Mar; 452(2):90-5. PubMed ID: 19154776
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Activated human microglia stimulate neuroblastoma cells to upregulate production of beta amyloid protein and tau: implications for Alzheimer's disease pathogenesis.
    Lee M; McGeer E; McGeer PL
    Neurobiol Aging; 2015 Jan; 36(1):42-52. PubMed ID: 25169677
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phenylbutyric acid reduces amyloid plaques and rescues cognitive behavior in AD transgenic mice.
    Wiley JC; Pettan-Brewer C; Ladiges WC
    Aging Cell; 2011 Jun; 10(3):418-28. PubMed ID: 21272191
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cytokine-producing microglia have an altered beta-amyloid load in aged APP/PS1 Tg mice.
    Babcock AA; Ilkjær L; Clausen BH; Villadsen B; Dissing-Olesen L; Bendixen AT; Lyck L; Lambertsen KL; Finsen B
    Brain Behav Immun; 2015 Aug; 48():86-101. PubMed ID: 25774009
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ADAM10 and ADAM17 are degraded by lysosomal pathway via asparagine endopeptidase.
    Zhang X; Tang L; Zhang Z
    Biochem Biophys Res Commun; 2021 Jan; 537():15-21. PubMed ID: 33383559
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neuroinflammation in Alzheimer's Disease: Microglia, Molecular Participants and Therapeutic Choices.
    Wang H; Shen Y; Chuang H; Chiu C; Ye Y; Zhao L
    Curr Alzheimer Res; 2019; 16(7):659-674. PubMed ID: 31580243
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of Cdk5 in Amyloid-beta Pathology of Alzheimer's Disease.
    Lu TT; Wan C; Yang W; Cai Z
    Curr Alzheimer Res; 2019; 16(13):1206-1215. PubMed ID: 31820699
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Revisiting the intersection of microglial activation and neuroinflammation in Alzheimer's disease from the perspective of ferroptosis.
    Wang M; Tang G; Zhou C; Guo H; Hu Z; Hu Q; Li G
    Chem Biol Interact; 2023 Apr; 375():110387. PubMed ID: 36758888
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Manipulation of microglial activation as a therapeutic strategy in Alzheimer's disease.
    Shie FS; Woltjer RL
    Curr Med Chem; 2007; 14(27):2865-71. PubMed ID: 18045132
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Contribution of inflammatory processes to Alzheimer's disease: molecular mechanisms.
    Sastre M; Klockgether T; Heneka MT
    Int J Dev Neurosci; 2006; 24(2-3):167-76. PubMed ID: 16472958
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Distance dependent shedding of IL-6R.
    Düsterhöft S; Bartels AK; Koudelka T; Lilienthal E; Schäfer M; Garbers C; Tholey A; Grötzinger J; Lorenzen I
    Biochem Biophys Res Commun; 2020 May; 526(2):355-360. PubMed ID: 32222277
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Microglia in Alzheimer's disease.
    Li Y; Tan MS; Jiang T; Tan L
    Biomed Res Int; 2014; 2014():437483. PubMed ID: 25197646
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.